Delaware's bioscience industry is one of the strongest per capita in the United States. Coupled with its neighboring states of Pennsylvania and New Jersey, the tri-state region represents 80% of the US pharmaceuticals industry. Strong academic research institutions working collaboratively with medical institutions and industry develop and commercialize many of the blockbuster drugs and the most innovative diagnostics and medical devices found anywhere in the world. All within a 50 mile radius and within a one to two hour drive of each other.
Global bioscience industry giants with significant Delaware research and or manufacturing operations include Agilent Technologies, AstraZeneca Pharmaceuticals, DuPont, Johnson & Johnson, Merck, Siemens Healthcare Diagnostics, Waters Corporation and within an hour's commute include Cephalon, Centocor, CSL Behring, Endo Pharmaceuticals, GSK, Pfizer, sanofi-aventis and more.
The 2009 study of the Delaware biopharmaceutical industry shows its economic impact on the State. Read more
The 2009 Milken Institute's report, The Greater Philadelphia Life Sciences Cluster 2009, highlights the strength of thebiopharma sector located in the Delaware, New Jersey and Pennsylvania counties surrounding Philadelphia. Read more
Key findings in above studies illustrate the significant contributions made by the biopharma industry to improve the human condition and to create and sustain very high paying jobs.